Algert Global’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8M | Buy |
+64,753
| New | +$2.8M | 0.06% | 526 |
|
|
2025
Q1 | – | Sell |
-23,600
| Closed | -$648K | – | 1183 |
|
|
2024
Q4 | $648K | Sell |
23,600
-112,847
| -83% | -$3.1M | 0.02% | 870 |
|
|
2024
Q3 | $3.47M | Buy |
136,447
+80,599
| +144% | +$2.05M | 0.09% | 372 |
|
|
2024
Q2 | $1.42M | Sell |
55,848
-33,558
| -38% | -$850K | 0.05% | 573 |
|
|
2024
Q1 | $2.76M | Buy |
89,406
+1,830
| +2% | +$56.6K | 0.11% | 311 |
|
|
2023
Q4 | $3.54M | Buy |
87,576
+22,012
| +34% | +$889K | 0.14% | 240 |
|
|
2023
Q3 | $1.73M | Buy |
65,564
+25,680
| +64% | +$677K | 0.08% | 411 |
|
|
2023
Q2 | $686K | Sell |
39,884
-2,430
| -6% | -$41.8K | 0.03% | 743 |
|
|
2023
Q1 | $702K | Sell |
42,314
-31,006
| -42% | -$514K | 0.03% | 746 |
|
|
2022
Q4 | $559K | Buy |
+73,320
| New | +$559K | 0.03% | 772 |
|
|
2022
Q3 | – | Sell |
-38,430
| Closed | -$349K | – | 1178 |
|
|
2022
Q2 | $349K | Sell |
38,430
-1,650
| -4% | -$15K | 0.03% | 876 |
|
|
2022
Q1 | $407K | Buy |
+40,080
| New | +$407K | 0.03% | 875 |
|